MarketCatalyst
← Back to Resources
Earnings

Absci Falls Short of Q3 2026 Estimates as Revenue Falls 20% to $304K

Revenue of $304K vs. $658K expected and adjusted EPS of -$0.19 vs. -$0.19; revenue down 20% from a year earlier.

Published Nov 12, 2026 · 7:41 AM ET · 2 min read

Absci (ABSI) fell short of estimates for the third quarter of 2026. Revenue was $304 thousand, down 20% from a year earlier, below the $658 thousand estimate, and adjusted EPS was -$0.19, up 5.0% from a year earlier, in line with the -$0.19 estimate.

Shares fell 3.7% in premarket trading as of 7:41 a.m. ET, to $9.75 from a $10.12 close.

-$0.19
Adjusted EPS, up 5.0% YoY vs. -$0.19 estimate
$304K
Revenue, down 20% YoY vs. $658K estimate
-3.7%
Shares premarket as of 7:41 a.m. ET

Q3 2026 scorecard

ParametersExpectedActualBeat/Miss
Adjusted EPS-$0.19-$0.19In line
Revenue$658K$304KMiss by 54%
ChangeYoYQoQ
Adjusted EPS▲ 5.0%▼ 5.6%
Revenue▼ 20%▲ 1.3%

By our calculation, revenue was $354 thousand below the estimate. The QoQ column compares with the previous quarter's revenue of $300 thousand and adjusted EPS of -$0.18. The YoY column compares with $378 thousand and -$0.20 in the same quarter a year earlier.

Track record

  • EPS record. Adjusted EPS beat the estimate in 3 of the last 8 reports, including this one.
  • Revenue record. Revenue beat the estimate in 0 of the last 8 reports.
  • Revenue trend. Revenue over the last 5 reports, oldest first: $378 thousand, $650 thousand, $215 thousand, $300 thousand and $304 thousand.

What to watch

  • Next-quarter estimates. Consensus calls for EPS of -$0.20 and revenue of $1.0 million next quarter, based on 5 analysts.
  • Revenue growth. Whether revenue stabilizes after this quarter's 20% decline from a year earlier to $304 thousand.
  • Estimate record. Whether Absci returns to beating EPS estimates, which it did in 3 of its last 8 reports.
  • Related coverage. See our reports on Intuitive Machines, ADI Global Distribution, Octave Intelligence and Twist Bioscience.

Sources: Results are from Absci's Nov. 12, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Absci's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.

Readers also read

MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.